Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome.
Òscar MiróSònia JiménezAlexandre MebazaaYonathan FreundGuillermo Burillo-PutzeAlfonso MartínFrancisco Javier Martín-SánchezEric Jorge García-LamberechtsAitor Alquézar-ArbéJavier JacobPere LlorensPascual PiñeraVíctor GilJosep GuardiolaCarlos CardozoJosep Maria Mòdol DeltellJosep TostAlfons Aguirre TejedoAnna Palau-VendrellLluís LLauger GarcíaMaria Adroher MuñozCarmen Del Arco GalánTeresa Agudo VillaNieves López-LagunaMaría Pilar López-DíezFahd Beddar ChaibEva Quero MottoMatilde González TejeraMaría Carmen PonceJuan González Del Castillonull nullPublished in: European heart journal (2021)
PE in COVID-19 patients at ED presentation is unusual (about 0.5%), but incidence is approximately ninefold higher than in the general (non-COVID-19) population. Moreover, risk factors and leg symptoms are less frequent, D-dimer increase is lower and emboli involve smaller pulmonary arteries. While PE probably does not increase the mortality of COVID-19 patients, mortality is higher in COVID-19 than in non-COVID-19 patients with PE.